Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André F, Hee Park Y, Kim SB, Takano T, Im SA, Borges G, Lima JP, Aksoy S, Gavila Gregori J, De Laurentiis M, Bianchini G, Roylance R, Miyoshi Y, Armstrong A, Sinha R, Ruiz Borrego M, Lim E, Ettl J, Yerushalmi R, Zagouri F, Duhoux FP, Fehm T, Gambhire D, Cathcart J, Wu C, Chu C, Egorov A, Krop I. André F, et al. Among authors: ruiz borrego m. Lancet. 2023 May 27;401(10390):1773-1785. doi: 10.1016/S0140-6736(23)00725-0. Epub 2023 Apr 20. Lancet. 2023. PMID: 37086745 Clinical Trial.
[Lung adenocarcinoma with rapid evolution in a 35-year-old patient].
Fuentes Pradera J, Fuentes Pradera MA, Ruiz Borrego M, Moreno Nogueira JA. Fuentes Pradera J, et al. Among authors: ruiz borrego m. Rev Clin Esp. 2004 Mar;204(3):177-8. doi: 10.1157/13058837. Rev Clin Esp. 2004. PMID: 15025991 Spanish. No abstract available.
[When the patient says "No"].
Viana Alonso A, Ruiz Borrego M, Bolaños Naranjo M, Moreno Nogueira JA. Viana Alonso A, et al. Among authors: ruiz borrego m. Med Clin (Barc). 1997 Sep 13;109(8):317. Med Clin (Barc). 1997. PMID: 9379756 Spanish. No abstract available.
[A case of 6 different neoplasms].
Ruiz Borrego M, Salvador Bofill J, Rizo Valero A, Noguer Mediavilla M. Ruiz Borrego M, et al. Rev Clin Esp. 1992 Jun;191(2):114-5. Rev Clin Esp. 1992. PMID: 1323866 Spanish. No abstract available.
[Epitrochlear Hodgkin's disease. Report of a new case].
Vicente Baz D, Ruiz Borrego M, Arriola Arellano E, Fernández-Freire A, Moreno Nogueira JA. Vicente Baz D, et al. Among authors: ruiz borrego m. An Med Interna. 2003 Jun;20(6):332. An Med Interna. 2003. PMID: 12848610 Spanish. No abstract available.
New insights into the role of the immune microenvironment in breast carcinoma.
de la Cruz-Merino L, Barco-Sánchez A, Henao Carrasco F, Nogales Fernández E, Vallejo Benítez A, Brugal Molina J, Martínez Peinado A, Grueso López A, Ruiz Borrego M, Codes Manuel de Villena M, Sánchez-Margalet V, Nieto-García A, Alba Conejo E, Casares Lagar N, Ibáñez Martínez J. de la Cruz-Merino L, et al. Among authors: ruiz borrego m. Clin Dev Immunol. 2013;2013:785317. doi: 10.1155/2013/785317. Epub 2013 Jun 3. Clin Dev Immunol. 2013. PMID: 23861693 Free PMC article. Review.
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.
Albanell J, González A, Ruiz-Borrego M, Alba E, García-Saenz JA, Corominas JM, Burgues O, Furio V, Rojo A, Palacios J, Bermejo B, Martínez-García M, Limon ML, Muñoz AS, Martín M, Tusquets I, Rojo F, Colomer R, Faull I, Lluch A. Albanell J, et al. Among authors: ruiz borrego m. Ann Oncol. 2012 Mar;23(3):625-631. doi: 10.1093/annonc/mdr278. Epub 2011 Jun 6. Ann Oncol. 2012. PMID: 21652577 Free article.
108 results